Búsqueda en vivo
TopFind está obteniendo las coincidencias más recientes para tu búsqueda.
Revisamos 12 resultados en vivo para skyrizi risankizumab rzaa y los redujimos a 3 opciones que parecen valer más la pena comparar primero.
Los temas más fuertes en esta lista son Immunology y Biologics.
Fuente: AbbVie Pharmaceuticals (Thailand) Ltd.
Descripción
Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading.
Ideal para
Plaque psoriasis patients, Psoriatic arthritis management, Crohn's disease treatment y Long Term biologic therapy
Valoración
Fuente: AbbVie Inc.
Descripción
Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body.
Ideal para
Moderate To Severe plaque psoriasis, Active psoriatic arthritis, Crohn's disease management, Ulcerative colitis treatment y Biologic therapy seekers
Valoración
Fuente: AbbVie Singapore
Descripción
Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia.
Ideal para
Regional medical reference, Singapore Based patients y Biologic therapy information
Valoración
| Comparar | Skyrizi (risankizumab) | Skyrizi (risankizumab-rzaa) | Skyrizi (risankizumab) 150mg |
|---|---|---|---|
| Fuente | AbbVie Pharmaceuticals (Thailand) Ltd. | AbbVie Inc. | AbbVie Singapore |
| Descripción | Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading. | Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body. | Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia. |
| Ideal para | Plaque psoriasis patients, Psoriatic arthritis management, Crohn's disease treatment y Long Term biologic therapy | Moderate To Severe plaque psoriasis, Active psoriatic arthritis, Crohn's disease management, Ulcerative colitis treatment y Biologic therapy seekers | Regional medical reference, Singapore Based patients y Biologic therapy information |
| Acción | |||
| Valoración |
Si quieres empezar con la opción más equilibrada, te recomiendo:
"Skyrizi (risankizumab) de AbbVie Pharmaceuticals (Thailand) Ltd.."
Lo elegí porque This is the official medication provided by the authorized manufacturer representative in Thailand, ensuring authentic pharmaceutical supply and regulatory oversight.